Clinical Trial

Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-04-17; most recent amendment 2026-06-15.
Trial Details
NCT Number NCT07548164
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: Angiodynamics, Inc.
Conditions Prostate Cancer
Enrollment 224 participants
Start Date 2026-04-16
Primary Completion 2029-04-16 (estimated)
Study Completion 2029-04-16 (estimated)
Updated on ClinicalTrials.gov 2026-06-16